UBS Group AG - ANNOVIS BIO INC ownership

ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 27 filers reported holding ANNOVIS BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ANNOVIS BIO INC
ValueSharesWeighting
Q3 2023$949
-33.6%
1000.0%0.00%
Q2 2023$1,429
-71.4%
100
-75.8%
0.00%
Q2 2022$5,000
-88.6%
414
-83.3%
0.00%
Q4 2021$44,000
+266.7%
2,481
+531.3%
0.00%
Q3 2021$12,000
-88.0%
393
-66.4%
0.00%
Q2 2021$100,0001,1680.00%
Other shareholders
ANNOVIS BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 463,797$3,497,0001.42%
Worth Venture Partners, LLC 119,538$901,0000.71%
Lokken Investment Group LLC 32,211$243,0000.22%
Sterling Investment Advisors, Ltd. 50,588$381,0000.13%
Modera Wealth Management, LLC 43,846$331,0000.03%
Cannell & Co. 10,000$75,0000.00%
Sowell Financial Services LLC 1,529$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 14,286$108,0000.00%
BROWN ADVISORY INC 14,942$113,0000.00%
View complete list of ANNOVIS BIO INC shareholders